Medical News

RSS

NO-ferroheme behaves as a signaling entity in the vasculature

Although a simple molecule, nitric oxide is an important signal substance that helps to reduce blood pressure by relaxing the blood vessels.

14 Sep 2023

Three quarters of trusts in England still use paper patient notes and drug charts

Three quarters of trusts in England that responded to a survey by The BMJ are still reliant on paper patient notes and drug charts, despite progress towards electronic records and prescribing.

14 Sep 2023

MIT study reveals why immunotherapy doesn't work for all cancer patients

This block is broken or missing. You may be missing content or you might need to enable the original module.

14 Sep 2023

Henry Ford Health performs first K-Clip procedure in the U.S. to treat severe tricuspid regurgitation

A team of interventional cardiologists from Henry Ford Health's Center for Structural Heart Disease recently became the first in the United States and the Western Hemisphere to repair a heart valve with severe tricuspid regurgitation in a patient using the investigational K-Clip™ Transvascular Tricuspid Repair System.

14 Sep 2023

NYU Langone doctors complete longest-documented case of pig kidney transplant in human body

After 61 days of observation, NYU Langone Health doctors this month completed the longest-documented case of a genetically engineered pig kidney functioning in a human body.

14 Sep 2023

Research suggests laminin could play role in slowing progression of breast tumors

Cells are capable of translating mechanical changes into biological responses. This process is known as mechanotransduction and plays a fundamental role in the progression of solid tumors, such as breast cancer.

14 Sep 2023

Harnessing the extraordinary capabilities of bio-nanoantennae to target and kill brain tumors

Researchers have discovered a new way to target and kill cancer cells in hard-to-treat brain tumors using electrically charged molecules to trigger self-destruction, that could be developed into a spray treatment used during surgery.

14 Sep 2023

NIH awards $3.2 million to study how unique DNA circles drive deadly pediatric brain tumors

Lukas Chavez, Ph.D., has received $3.2 million from the National Institutes of Health to study how unique DNA circles found in cancer cells drive deadly pediatric brain tumors.

14 Sep 2023

UKHSA's flagship SIREN study enters new phase to continue surveillance of respiratory pathogens

The next phase of the study will be known as SIREN 2.0 and began in September 2023.

14 Sep 2023

New nano-thin superbug-slaying material could revolutionize wound healing

Researchers have invented a nano-thin superbug-slaying material that could one day be integrated into wound dressings and implants to prevent or heal bacterial infections.

14 Sep 2023

UT Health San Antonio and UTSA launch first U.S. MD/MS program in medicine and artificial intelligence

The Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and the University College at The University of Texas at San Antonio (UTSA) are officially launching the first known program in the United States to combine medicine and artificial intelligence.

14 Sep 2023

Peer-led navigation program improves mental health outcomes for racially and ethnically minoritized veterans

Research scientists led by Johanne Eliacin, PhD, of the U.S. Department of Veterans' Affairs (VA) and Regenstrief Institute, have developed PARTNER-MH, an innovative, peer-led patient navigation program to support racially and ethnically minoritized veterans seeking mental healthcare, regardless of the types of mental health services needed or their mental health diagnoses.

14 Sep 2023

Eris sublineage EG.5.1 can escape neutralizing antibodies better than other SARS-CoV-2 lineages

As a result of vaccination or infection, our immune system produces antibodies that attach to the spike protein of SARS-CoV-2, preventing the virus from entering and replicating within cells.

14 Sep 2023

New trial shows promise of combination neoadjuvant immunotherapy for lung cancer

Patients with stage 1–3 non-small cell lung cancer (NSCLC) given a combination immunotherapy prior to surgery (neoadjuvant) had a better major pathological response (10% or less residual cancer) when the cancer was removed than those who took a single immunotherapy agent alone, according to results of a novel multicenter phase 2 NeoCOAST platform trial that included two investigators from the Johns Hopkins Kimmel Cancer Center and its Bloomberg-Kimmel Institute for Cancer Immunotherapy.

14 Sep 2023

Geographic disparities in breast cancer mortality: how where you live could matter

A new paper recently published in JAMA Network Open explores the differential mortality rates across various US counties regarding their geographic location associated with multiple sociodemographic factors.

14 Sep 2023

Multi-omics study offers insights into psoriasis treatment

Researchers use a multi-omics approach combining immune cell-enriched scRNA-seq, microarray analysis, and immunohistochemistry to elucidate the translational role of anti-IL-17A in suppressing the autoimmune functions of T17 cells, thereby effectively treating human psoriasis.

14 Sep 2023

Medical News

NO-ferroheme behaves as a signaling entity in the vasculature

Three quarters of trusts in England still use paper patient notes and drug charts

MIT study reveals why immunotherapy doesn't work for all cancer patients

Henry Ford Health performs first K-Clip procedure in the U.S. to treat severe tricuspid regurgitation

NYU Langone doctors complete longest-documented case of pig kidney transplant in human body

Research suggests laminin could play role in slowing progression of breast tumors

Harnessing the extraordinary capabilities of bio-nanoantennae to target and kill brain tumors

NIH awards $3.2 million to study how unique DNA circles drive deadly pediatric brain tumors

UKHSA's flagship SIREN study enters new phase to continue surveillance of respiratory pathogens

New nano-thin superbug-slaying material could revolutionize wound healing

UT Health San Antonio and UTSA launch first U.S. MD/MS program in medicine and artificial intelligence

Peer-led navigation program improves mental health outcomes for racially and ethnically minoritized veterans

Eris sublineage EG.5.1 can escape neutralizing antibodies better than other SARS-CoV-2 lineages

New trial shows promise of combination neoadjuvant immunotherapy for lung cancer

Geographic disparities in breast cancer mortality: how where you live could matter

Multi-omics study offers insights into psoriasis treatment

Reviving reservoirs: new findings shake up HIV treatment understanding

MRI innovation to unveil iron homeostasis in the human brain

Study suggests link between blood transfusions and brain hemorrhages, but further research needed

A novel multi-epitope vaccine targeting extracellular proteins of Chlamydia pneumoniae

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News